It's
#NewMemberMonday!
🧠
#ClicBio develops oral CLIC1 inhibitors that suppress hunger by modulating hypothalamic neurons, offering a GLP-1-independent pathway to treat obesity and metabolic disease.
🫀
#Corvention develops innovative medical devices to advance structural heart procedures and improve patient outcomes.
🧪
#Onepot automates on‑demand compound synthesis by combining AI‑driven route design with robotic medicinal chemistry execution.
🔬
#Sarmal develops next-generation nucleic acid sequencing and detection platforms to make genomics fast, affordable, and field-deployable..
🦠
@sciotobio develops live bacterial therapeutics using its Activated Bacterial Therapeutics platform to treat GI disorders, autism and conditions along the gut-brain axis.
🧬
@SundanceBio develops next‑generation TYK2‑targeted therapies to treat multiple sclerosis and immune‑mediated disorders.
ALT Please join us in welcoming our new members to the Biocom community. ClicBio, Corvention, Onepot, Sarmal, Scioto Biosciences and Sundance Biosciences.